Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
MarineMax
HZO
$795M
| $724K | ﹤0.01% |
25,192
+2,358
| +10% | +$74.1K |
|
|
PMT
2902
PennyMac Mortgage Investment
PMT
$822M
| $721K | ﹤0.01% |
58,444
+15,426
| +36% | +$207K |
|
2903
Astrana Health
ASTH
$1.75B
| $720K | ﹤0.01% |
19,755
+761
| +4% | +$26.6K |
|
2904
Adtran
ADTN
$732M
| $720K | ﹤0.01% |
45,407
+7,030
| +18% | +$122K |
|
2905
Aclaris Therapeutics
ACRS
$814M
| $718K | ﹤0.01% |
88,690
+45,880
| +107% | +$582K |
|
2906
Griffon
GFF
$4.26B
| $717K | ﹤0.01% |
22,401
-10,057
| -31% | -$368K |
|
2907
Shell
SHEL
$247B
| $717K | ﹤0.01% |
12,455
-39,712
| -76% | -$2.34M |
|
2908
Unisys
UIS
$222M
| $715K | ﹤0.01% |
184,381
+127,178
| +222% | +$614K |
|
2909
TTM Technologies
TTMI
$14B
| $715K | ﹤0.01% |
53,020
-9,956
| -16% | -$144K |
|
2910
Paysafe
PSFE
$409M
| $715K | ﹤0.01% |
41,379
+4,336
| +12% | +$84.4K |
|
|
HGAS
2911
DELISTED
Global Gas Corporation Class A Common Stock
HGAS
| $714K | ﹤0.01% |
72,163
| – | – |
|
2912
Miller Industries
MLR
$572M
| $714K | ﹤0.01% |
20,187
+909
| +5% | +$26.9K |
|
2913
Horace Mann Educators
HMN
$2.09B
| $713K | ﹤0.01% |
21,299
+1,463
| +7% | +$52.3K |
|
|
JHG
2914
DELISTED
Janus Henderson
JHG
| $713K | ﹤0.01% |
26,746
-52,099
| -66% | -$1.39M |
|
|
NVEE
2915
DELISTED
NV5 Global
NVEE
| $712K | ﹤0.01% |
27,400
+2,160
| +9% | +$64.8K |
|
2916
Stewart Information Services
STC
$2.08B
| $711K | ﹤0.01% |
17,618
-8,557
| -33% | -$375K |
|
2917
Energy Fuels
UUUU
$3.16B
| $710K | ﹤0.01% |
127,227
+37,057
| +41% | +$240K |
|
2918
Sana Biotechnology
SANA
$927M
| $709K | ﹤0.01% |
216,848
-86,262
| -28% | -$345K |
|
2919
ATN International
ATNI
$380M
| $707K | ﹤0.01% |
17,289
+427
| +3% | +$18.9K |
|
2920
Amalgamated Financial
AMAL
$1.49B
| $707K | ﹤0.01% |
39,965
+17,589
| +79% | +$387K |
|
|
CHCT
2921
Community Healthcare Trust
CHCT
$514M
| $705K | ﹤0.01% |
19,274
-6,927
| -26% | -$270K |
|
|
PRO
2922
DELISTED
PROS Holdings
PRO
| $705K | ﹤0.01% |
25,726
+13,139
| +104% | +$342K |
|
2923
Inovio Pharmaceuticals
INO
$70M
| $704K | ﹤0.01% |
71,565
-41,236
| -37% | -$703K |
|
|
SAMA
2924
DELISTED
Schultze Special Purpose Acquisition Corp. II Class A Common Stock
SAMA
| $703K | ﹤0.01% |
68,358
| – | – |
|
|
STET
2925
DELISTED
ST Energy Transition I Ltd.
STET
| $703K | ﹤0.01% |
67,698
| – | – |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.